First Trust Advisors LP Cytom X Therapeutics, Inc. Transaction History

First Trust Advisors LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 30, 2019	SELL	$9.35 - $11.41 $228,990 - $279,442	-24,491 Closed	0 $0
Q1 2019 May 09, 2019	BUY	$9.5 - $19.16 $232,664 - $469,247	24,491 New	24,491 $263,000
Q4 2018 Feb 07, 2019	SELL	$12.69 - $18.61 $1.22 Million - $1.78 Million	-95,805 Closed	0 $0
Q3 2018 Oct 25, 2018	SELL	$18.04 - $26.41 $736,627 - $1.08 Million	-40,833 Reduced 29.88%	95,805 $1.77 Million
Q2 2018 Aug 02, 2018	BUY	$21.38 - $29.68 $2.92 Million - $4.06 Million	136,638 New	136,638 $3.12 Million

49.4M

112K

8.3K

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $55.4M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

Stay updated on First Trust Advisors LP with notifications on news.